Faeth Therapeutics, Inc <FTH.O>: Needham initiates coverage with Buy rating; price target $56
FTH•Related News
Trump to ease ground beef import quotas for 90 days
XLP•
LifeVantage declares quarterly dividend of $0.05 per share
LFVN•
Ultragenyx Pharmaceutical Inc. <RARE.O>: Morgan Stanley Raises Target Price to $74 From $67
RARE•
Eric Trump-backed Space-Eyes to appoint ex-Delta Force officer and ex-banker, sources say
MKLY•
Mobility Global <MBGL.N>: Bofa Global Research Initiates Coverage With Neutral Rating And Price Objective $23.00
MBGL•